Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2009, p. 4022-4024, Vol. 53, No. 9
0066-4804/09/$08.00+0 doi:10.1128/AAC.00145-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

and
Elizabeth Reinosa1
Universidad Tecnológica de Pereira, Centro de Biología Molecular y Biotecnología, Laboratorio de Microbiología y Parasitología, Pereira, Colombia,1 Universidad de Caldas, Departamento Clínico Quirúrgico, Manizales, Colombia2
Received 30 January 2009/ Returned for modification 8 May 2009/ Accepted 14 June 2009
Resistance to metronidazole, clarithromycin, and amoxicillin (amoxicilline) was found in 82, 3.8, and 1.9% of 106 Helicobacter pylori isolates, respectively. No tetracycline-resistant isolates were found. In all of the clarithromycin-resistant isolates, only one point mutation was present, either A2143G or A2142G. Our results indicate that metronidazole should not be included in the empirical treatment of H. pylori infection in this region.
Published ahead of print on 22 June 2009.
Present address: Fundación Universitaria del Área Andina, Carrera 24 No. 8-55, Pereira, Colombia.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»